| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 47.2205 | 38 |
| GSM780708 | Untreated after 4 days (C2_1) | 35.3365 | 1 |
| GSM780709 | Untreated after 4 days (C3_1) | 42.4887 | 15 |
| GSM780719 | Untreated after 4 days (C1_2) | 45.1038 | 28 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.4155 | 19 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.8532 | 26 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 47.2632 | 38 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.9206 | 32 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 39.5141 | 5 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.636 | 30 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 42.8727 | 17 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 40.3217 | 7 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.2251 | 33 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.6568 | 20 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 41.9784 | 13 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 39.2737 | 5 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 39.0145 | 4 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 41.2094 | 10 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.4027 | 11 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 50.1617 | 49 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 37.4615 | 2 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 37.6926 | 2 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.8472 | 31 |